StockWatch
·

SANDU PHARMACEUTICALS LTD. Q3 FY25 Results

SANDUPHQQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue18.373.8%
Total Income18.403.7%
Expenditure17.603.6%
PBT0.807.4%
Net Profit0.5611.2%
OPM3.03%0.13pp
NPM3.02%0.20pp
EPS0.579.6%
View full financials

Informational and educational content only. Not investment advice.